Comparison of Hippocampal Volume Change after Whole-Brain Radiotherapy with and without Hippocampal Avoidance: A Post-Hoc Analysis of a Phase II Randomized Trial

被引：0
|
作者：
Liu, T. F. [1 ]
Chen, Y. F. [2 ]
Hsu, F. M. [1 ,3 ]
Yang, W. C. [3 ,4 ]
机构：
[1] Natl Taiwan Univ Hosp, Dept Oncol, Div Radiat Oncol, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Dept Med Imaging, Taipei, Taiwan
[3] Natl Taiwan Univ, Grad Inst Oncol, Coll Med, Taipei, Taiwan
[4] Natl Taiwan Univ, Ctr Canc, Dept Radiat Oncol, Taipei, Taiwan
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2023年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2283
引用
收藏
页码：E131 / E131
页数：1
相关论文
共 50 条
  • [41] Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) – a phase II prospective randomized multicenter trial (NOA-14, ARO 2015–3, DKTK-ROG)
    Anca-Ligia Grosu
    Lars Frings
    Iryna Bentsalo
    Oliver Oehlke
    Franziska Brenner
    Angelika Bilger
    Jamina Tara Fennell
    Thomas Rothe
    Sabine Schneider-Fuchs
    Erika Graf
    Claudia Schmoor
    Jürgen Beck
    Gerhild Becker
    Michael Bock
    Karl Egger
    Horst Urbach
    Claas Lahmann
    Ilinca Popp
    [J]. BMC Cancer, 20
  • [42] Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG)
    Grosu, Anca-Ligia
    Frings, Lars
    Bentsalo, Iryna
    Oehlke, Oliver
    Brenner, Franziska
    Bilger, Angelika
    Fennell, Jamina Tara
    Rothe, Thomas
    Schneider-Fuchs, Sabine
    Graf, Erika
    Schmoor, Claudia
    Beck, Jurgen
    Becker, Gerhild
    Bock, Michael
    Egger, Karl
    Urbach, Horst
    Lahmann, Claas
    Popp, Ilinca
    [J]. BMC CANCER, 2020, 20 (01)
  • [43] Prognostic value of lymphocytes in patients with breast cancer receiving radiotherapy after breast-conserving surgery: A post hoc analysis of a phase III randomized trial
    Song, Yu-Chun
    Chen, Si-Ye
    Zhao, Xu-Ran
    Jing, Hao
    Fang, Hui
    Tang, Yu
    Hu, Shang-Ying
    Song, Yong-Wen
    Jin, Jing
    Liu, Yue-Ping
    Qi, Shu-Nan
    Sun, Guang-Yi
    Zhong, Qiu-Zi
    Du, Xiang-Hui
    Liu, Juan
    Li, Ye-Xiong
    Wang, Shu-Lian
    [J]. RADIOTHERAPY AND ONCOLOGY, 2024, 199
  • [44] Health-Related Quality-of-Life after Laparoscopic Gastric Bypass Surgery with or Without Closure of the Mesenteric Defects: a Post-hoc Analysis of Data from a Randomized Clinical Trial
    Erik Stenberg
    Eva Szabo
    Johan Ottosson
    Anders Thorell
    Ingmar Näslund
    [J]. Obesity Surgery, 2018, 28 : 31 - 36
  • [45] Dosimetric Impact of Interfractional Bladder and Trigone Deformations: A Post-Hoc Analysis of a Phase III Randomized Trial of MRI-Guided vs. CT-Guided Stereotactic Body Radiotherapy
    Neilsen, B. K.
    Ma, T. M.
    Neylon, J. P.
    Casado, M.
    Sharma, S.
    Sheng, K.
    Low, D.
    Yang, Y.
    Steinberg, M. L.
    Lamb, J. M.
    Cao, M.
    Kishan, A. U.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : E234 - E235
  • [46] Health-Related Quality-of-Life after Laparoscopic Gastric Bypass Surgery with or Without Closure of the Mesenteric Defects: a Post-hoc Analysis of Data from a Randomized Clinical Trial
    Stenberg, Erik
    Szabo, Eva
    Ottosson, Johan
    Thorell, Anders
    Naslund, Ingmar
    [J]. OBESITY SURGERY, 2018, 28 (01) : 31 - 36
  • [47] BASELINE FACTORS ASSOCIATED WITH LUPUS FLARES: A POST-HOC ANALYSIS OF PATIENTS WITH MODERATE TO SEVERE ACTIVE SYSTEMIC LUPUS ERYTHEMATOSUS ENROLLED IN A 48 WEEK PHASE II RANDOMIZED CLINICAL TRIAL
    Lindsay, L.
    Mao, H. A.
    Cheng, J. E.
    Chuo, C. Y.
    Jones, N.
    Cascino, M. D.
    Tuckwell, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 648 - 648
  • [48] Best time to assess complete clinical response after chemoradiotherapy in squamous cell carcinoma of the anus (ACT II): a post-hoc analysis of randomised controlled phase 3 trial
    Glynne-Jones, Robert
    Sebag-Montefiore, David
    Meadows, Helen M.
    Cunningham, David
    Begum, Rubina
    Adab, Fawzi
    Benstead, Kim
    Harte, Robert J.
    Stewart, Jill
    Beare, Sandy
    Hackshaw, Allan
    Kadalayil, Latha
    [J]. LANCET ONCOLOGY, 2017, 18 (03): : 347 - 356
  • [49] The role of adaptive planning in margin-reduced, MRI-guided stereotactic body radiotherapy to the prostate bed following radical prostatectomy: Post-hoc analysis of a phase II clinical trial
    Nikitas, John
    Smith, Lauren M.
    Gao, Yu
    Ma, Ting Martin
    Sachdeva, Ankush
    Yoon, Stephanie M.
    Jiang, Tommy
    Low, Daniel A.
    Ballas, Leslie K.
    Steinberg, Michael L.
    Cao, Minsong
    Kishan, Amar U.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2023, 183
  • [50] Impact of ROS1, ALK, and/or MET expression level on the therapeutic efficacy of GEMOX with and without cetuximab in ABTC: A post hoc analysis of a randomized phase II trial
    Chiang, Nai-Jung
    Hsu, Chiun
    Chen, Jen-Shi
    Tsou, Hiso-Hui
    Chao, Yee
    Shan, Yang-Shen
    Huang, Shiu-Feng
    Chiu, Chang-Fang
    Lee, Kuan-Der
    Chen, Li-Tzong
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
12345